Erlotinib Completed Phase 1 Trials for Advanced/Recurrent Non-small-cell Lung Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01251796A Study of ARQ 197 in Combination With Erlotinib